---
title: "15:21 ET$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294728902.md"
description: "Monteverde & Associates PC is investigating potential class action lawsuits regarding four mergers: Arcosa's sale to CRH Americas, Crinetics' sale to Vertex Pharmaceuticals, Leggett & Platt's sale to Somnigroup International, and LivePerson's sale to SoundHound AI. The firm urges shareholders of these companies to review the proposed transactions and shareholder vote dates."
datetime: "2026-08-03T19:21:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294728902.md)
  - [en](https://longbridge.com/en/news/294728902.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294728902.md)
---

# 15:21 ET$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN

, /PRNewswire/ -- **Class Action Attorney** Juan Monteverde **with** Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50 Firm** in the 2025 ISS Securities Class Action Services Report. We are headquartered at the **Empire State Building** in New York City and are investigating

-   **Arcosa, Inc. (NYSE:** **ACA****)** related to its sale to CRH Americas, Inc. Under the terms of the proposed transaction, Arcosa shareholders are expected to receive $150.00 per share in cash.

**ACT NOW. The Shareholder Vote is scheduled for September 4, 2026.**

**Click here for more info** **https://monteverdelaw.com/case/arcosa-inc/****.** **It is free and there is no cost or obligation to you.**

-   **Crinetics Pharmaceuticals, Inc. (NASDAQ:** **CRNX****)** related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected to receive $85.00 per share in cash.

**ACT NOW. The Shareholder Vote is scheduled for August 28, 2026.**

**Click here for more information** **https://monteverdelaw.com/case/crinetics-pharmaceuticals-inc/****.** **It is free and there is no cost or obligation to you.**

-   **Leggett & Platt, Incorporated (NYSE:** **LEG****)** related to its sale to Somnigroup International Inc. Under the terms of the proposed transaction, Leggett & Platt shareholders will receive 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt common stock.

**ACT NOW. The Shareholder Vote is scheduled for August 20, 2026.**

**Click here for more information** **https://monteverdelaw.com/case/leggett-platt-incorporated/****.** **It is free and there is no cost or obligation to you.**

-   **LivePerson, Inc. (NASDAQ:** **LPSN****)** related to its sale to SoundHound AI, Inc. for an equity value of $43 million.

**ACT NOW. The Shareholder Vote is scheduled for August 20, 2026.**

**Click here for more info** **https://monteverdelaw.com/case/liveperson-inc/****.** **It is free and there is no cost or obligation to you.**

**NOT ALL LAW FIRMS ARE THE SAME.** Before you hire a law firm, you should talk to a lawyer and ask:

1.  Do you file class actions and go to Court?
2.  When was the last time you recovered money for shareholders?
3.  What cases did you recover money in and how much?

**About Monteverde & Associates PC**

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.

**No company, director or officer is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341.

Contact:  
Juan Monteverde, Esq.  
MONTEVERDE & ASSOCIATES PC  
**The Empire State Building  
**350 Fifth Ave. Suite 4740  
New York, NY 10118  
United States of America  
\[email protected\]  
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE Monteverde & Associates PC

### Related Stocks

- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)
- [LEG.US](https://longbridge.com/en/quote/LEG.US.md)
- [LPSN.US](https://longbridge.com/en/quote/LPSN.US.md)
- [ACA.US](https://longbridge.com/en/quote/ACA.US.md)
- [SGI.US](https://longbridge.com/en/quote/SGI.US.md)
- [CRH.US](https://longbridge.com/en/quote/CRH.US.md)
- [SOUN.US](https://longbridge.com/en/quote/SOUN.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [SOUX.US](https://longbridge.com/en/quote/SOUX.US.md)
- [SOUNW.US](https://longbridge.com/en/quote/SOUNW.US.md)

## Related News & Research

- [Arcosa announces special shareholder meeting on merger deal](https://longbridge.com/en/news/294675910.md)
- [SoundHound AI Q2 Earnings on August 5 — 3 Catalysts That Could Move SOUN Stock](https://longbridge.com/en/news/294694242.md)
- [CRNX: Vertex acquisition announced as PALSONIFY drives Q2 revenue surge amid ongoing pipeline progress](https://longbridge.com/en/news/294732893.md)
- [Carmignac Gestion Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/294662029.md)
- [CRH Q2 Earnings Call Highlights](https://longbridge.com/en/news/294456786.md)